High‐throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High‐throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF IMMUNOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-10-17
DOI
10.1002/eji.201948241
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies
- (2018) Benjamin F. Tillman et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The PI3Kδ-Selective Inhibitor Idelalisib Minimally Interferes with Immune Effector Function Mediated by Rituximab or Obinutuzumab and Significantly Augments B Cell Depletion In Vivo
- (2018) Adam Palazzo et al. JOURNAL OF IMMUNOLOGY
- Chronic lymphocytic leukaemia
- (2018) Michael Hallek et al. LANCET
- Dual loss of p110δ PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features
- (2017) Nigel Sharfe et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Plasma cell survival in the absence of B cell memory
- (2017) Erika Hammarlund et al. Nature Communications
- mTOR has distinct functions in generating versus sustaining humoral immunity
- (2016) Derek D. Jones et al. JOURNAL OF CLINICAL INVESTIGATION
- A human immunodeficiency caused by mutations in the PIK3R1 gene
- (2015) Marie-Céline Deau et al. JOURNAL OF CLINICAL INVESTIGATION
- Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
- (2015) Jolien Suurmond et al. JOURNAL OF CLINICAL INVESTIGATION
- Differential Effects of Tacrolimus versus Sirolimus on the Proliferation, Activation and Differentiation of Human B Cells
- (2015) Opas Traitanon et al. PLoS One
- mTOR kinase inhibitors promote antibody class switching via mTORC2 inhibition
- (2014) Jose J. Limon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Requirement for Rictor in homeostasis and function of mature B lymphoid cells
- (2013) K. Lee et al. BLOOD
- Identification of B Cell Defects Using Age-Defined Reference Ranges for In Vivo and In Vitro B Cell Differentiation
- (2013) D. J. aan de Kerk et al. JOURNAL OF IMMUNOLOGY
- B Cell-Specific Deficiencies in mTOR Limit Humoral Immune Responses
- (2013) S. Zhang et al. JOURNAL OF IMMUNOLOGY
- Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
- (2013) Carrie L Lucas et al. NATURE IMMUNOLOGY
- Phosphoinositide 3-Kinase Gene Mutation Predisposes to Respiratory Infection and Airway Damage
- (2013) I. Angulo et al. SCIENCE
- mTOR, linking metabolism and immunity
- (2013) Xiaojin Xu et al. SEMINARS IN IMMUNOLOGY
- Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
- (2013) Matthieu Mahévas et al. Frontiers in Immunology
- Regulation of Immune Responses by mTOR
- (2012) Jonathan D. Powell et al. Annual Review of Immunology
- Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
- (2012) Sebastian Eickenberg et al. ARTHRITIS RESEARCH & THERAPY
- Akt and mTOR in B Cell Activation and Differentiation
- (2012) Jose J. Limon et al. Frontiers in Immunology
- Direct activation of mTOR in B lymphocytes confers impairment in B-cell maturation andloss of marginal zone B cells
- (2011) Sandrine Benhamron et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Phase I, Dose-Escalation Study of BKM120, an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors
- (2011) Johanna C. Bendell et al. JOURNAL OF CLINICAL ONCOLOGY
- Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation
- (2011) J. L. Karnell et al. JOURNAL OF IMMUNOLOGY
- Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production
- (2010) S. Zhang et al. BLOOD
- Key factors in mTOR regulation
- (2009) Xiaochun Bai et al. CELLULAR AND MOLECULAR LIFE SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started